Compare PPIH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | SXTC |
|---|---|---|
| Founded | 1993 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.6M | 184.5M |
| IPO Year | N/A | 2019 |
| Metric | PPIH | SXTC |
|---|---|---|
| Price | $32.21 | $1.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 78.6K | ★ 199.0K |
| Earning Date | 12-12-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $200,783,000.00 | $1,740,907.00 |
| Revenue This Year | $25.58 | N/A |
| Revenue Next Year | $8.72 | N/A |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | ★ 30.74 | N/A |
| 52 Week Low | $8.81 | $0.95 |
| 52 Week High | $36.48 | $7.84 |
| Indicator | PPIH | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 73.16 | 64.64 |
| Support Level | $27.63 | $1.35 |
| Resistance Level | $36.48 | $1.78 |
| Average True Range (ATR) | 1.60 | 0.09 |
| MACD | 0.72 | 0.02 |
| Stochastic Oscillator | 68.33 | 66.67 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.